Cogent Biosciences COGT
NASDAQ COGT
$31.66 -0.20 (-0.63%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Current Assets (2017 - 2026)

Updated

Cogent Biosciences (COGT) posted Current Assets of $804.82 million for Q2 2026, up 228.5% from $245.01 million a year earlier but down 8.3% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Current Assets (2017 - 2026) Analysis & Trends

At the end of FY2025, Cogent Biosciences' Current Assets came in at $910.36 million, up 207.1% from FY2024.

  • Annual Current Assets has increased for four consecutive years, with a five-year compound annual growth rate of 30.0% (FY2020 to FY2025).
  • In prior years, Cogent Biosciences' Current Assets was $296.47 million in FY2024 (+9.5%), $270.77 million in FY2023 (+2.2%), $264.97 million in FY2022 (+19.0%) and $222.63 million in FY2021 (-9.1%).
  • Quarterly Current Assets has run from a low of $194.73 million in Q1 2022 to a high of $910.36 million in Q4 2025 over five years.
  • On a year-over-year basis, Current Assets has increased in each of the last four quarters, with growth averaging 81.4% over the last eight quarters.
  • The strongest year-over-year quarter for Current Assets in the past five years was Q1 2026, with growth of 247.1%; the weakest was Q1 2025, with a decline of 42.8%.
  • According to Business Quant data, Current Assets for the three prior quarters was $877.8 million (Q1 2026), $910.36 million (Q4 2025) and $397.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Cogent Biosciences 5.47 Bn 5.47 Bn - 804.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 804.82 Mn
Mar 31, 2026 877.80 Mn
Dec 31, 2025 910.36 Mn
Sep 30, 2025 397.24 Mn
Jun 30, 2025 245.01 Mn
Mar 31, 2025 252.88 Mn
Dec 31, 2024 296.47 Mn
Sep 30, 2024 341.53 Mn
Jun 30, 2024 369.97 Mn
Mar 31, 2024 441.90 Mn
Dec 31, 2023 270.77 Mn
Sep 30, 2023 285.95 Mn
Jun 30, 2023 334.52 Mn
Mar 31, 2023 226.27 Mn
Dec 31, 2022 264.97 Mn
Sep 30, 2022 296.42 Mn
Jun 30, 2022 330.68 Mn
Mar 31, 2022 194.73 Mn
Dec 31, 2021 222.63 Mn
Sep 30, 2021 207.50 Mn
API Access

Cogent Biosciences Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=COGT&period=max&api_key=YOUR_API_KEY